Loading…
Risk factors for breakthrough COVID‐19 infections in solid organ transplant recipients receiving tixagevimab/cilgavimab for pre‐exposure prophylaxis
Saved in:
Published in: | Transplant infectious disease 2023-12, Vol.25 (6), p.e14125-n/a |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | |
---|---|
ISSN: | 1398-2273 1399-3062 |
DOI: | 10.1111/tid.14125 |